Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
S Zhang, Y Li, G Liu, B Su - Thrombosis Journal, 2021 - Springer
Background Anticoagulation in hospitalized COVID-19 patients has been associated with
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …
survival benefit; however, the optimal anticoagulant strategy has not yet been defined. The …
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis
MC Vedovati, M Graziani, G Agnelli… - Internal and Emergency …, 2023 - Springer
Venous thromboembolism (VTE) is common in patients with coronavirus disease-2019
(COVID-19). The optimal heparin regimen remains unknown and should balance …
(COVID-19). The optimal heparin regimen remains unknown and should balance …
Thrombosis and bleeding after implementation of an intermediate-dose prophylactic anticoagulation protocol in ICU patients with COVID-19: a multicenter screening …
K Al-Abani, N Kilhamn, E Maret… - Journal of Intensive …, 2022 - journals.sagepub.com
Thrombosis and bleeding after implementation of an intermediate-dose prophylactic
anticoagulation protocol in intensive care unit (ICU) patients with coronavirus disease 2019 …
anticoagulation protocol in intensive care unit (ICU) patients with coronavirus disease 2019 …
[HTML][HTML] Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
A Kollias, G Poulakou, E Dimakakos… - Thrombosis …, 2021 - ncbi.nlm.nih.gov
Moll et al. recently published a retrospective analysis of COVID-19 patients admitted to
intensive care unit (ICU) from a single tertiarycare academic hospital showing that there was …
intensive care unit (ICU) from a single tertiarycare academic hospital showing that there was …
Impact of thromboprophylaxis intensity on patients' mortality among hospitalized patients with COVID-19: a propensity-score matched study
Purpose Venous thromboembolism (VTE), a major complication that has been reported in
patients with COVID-19, is associated with an increased risk of mortality. The purpose of this …
patients with COVID-19, is associated with an increased risk of mortality. The purpose of this …
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 …
M Guo, Q Han, J Xing, F Xu, J Wang, C Li… - … and Critical Care …, 2022 - journals.lww.com
Background Anticoagulants are promising regimens for treating coronavirus disease 2019
(COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is …
(COVID-19). However, whether prophylactic or intermediate-to-therapeutic dosage is …
[HTML][HTML] SARS-CoV-2 gamma variant and chronic arterial insufficiency due to late arterial thrombosis
JMP de Godoy, G Marum, HA Santos… - … Journal of Health …, 2022 - ncbi.nlm.nih.gov
The current evidence suggests a state of hypercoagulability as one of the sequelae of
hyperinflammation. Thus, it is an important pathogenic mechanism that contributes to …
hyperinflammation. Thus, it is an important pathogenic mechanism that contributes to …
[HTML][HTML] When to use anticoagulation in COVID-19
M Moll, JM Connors - Thrombosis Research, 2021 - ncbi.nlm.nih.gov
Early in the COVID-19 pandemic, infection with SARS-CoV-2 was noted to be associated
with a coagulopathy [1] and high rates of VTE observed in ICU patients, leading many to …
with a coagulopathy [1] and high rates of VTE observed in ICU patients, leading many to …
[HTML][HTML] Akútna pľúcna embólia
M Belicová, D Prídavková, V Jankovičová… - Cor et …, 2021 - actavia.e-coretvasa.cz
Background: Pulmonary embolism is relatively a frequent and dangerous disease with
varied manifestations ranging from benign to fatal. The authors in a retrospective study …
varied manifestations ranging from benign to fatal. The authors in a retrospective study …
SARS-CoV-2 gamma variant and chronic arterial insufficiency due to late arterial thrombosis.
JM Pereira de Godoy, G Marum… - Journal of Health …, 2022 - search.ebscohost.com
The current evidence suggests a state of hypercoagulability as one of the sequelae of
hyperinflammation. Thus, it is an important pathogenic mechanism that contributes to …
hyperinflammation. Thus, it is an important pathogenic mechanism that contributes to …